NICOLE MARTIN: Open Payments
NPI 1154092344 · SOUTHBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,065 in 118 payments from 19 companies in 2025. Trend: 2023 $1,111 · 2024 $1,974 · 2025 $2,065
Food & beverage: $2,065
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $451 |
| GlaxoSmithKline, LLC. | 16 | $283 |
| Lilly USA, LLC | 12 | $233 |
| PFIZER INC. | 17 | $230 |
| AstraZeneca Pharmaceuticals LP | 10 | $225 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $135 |
| Novo Nordisk Inc | 5 | $116 |
| Exact Sciences Corporation | 5 | $101 |
| Sumitomo Pharma America, Inc. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: VRAYLAR, TRELEGY ELLIPTA, BREZTRI, JARDIANCE, XIFAXAN, QULIPTA, PREVNAR 20, The Cologuard Plus Collection Kit.
Industry payments across CT — which companies pay providers there.
